3 New Strong Buy Ratings from Top-Rated Analysts: 06/02/2026
Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener…
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
Windfall Profit Potential For These 5 Summer Stocks From peak travel demand to the World Cup to home improvement season, summer drives the business behind each of these 5 companies. This free report covers the catalysts, fundamentals and analyst price targets. Click here to access your free copy.1. Amneal Pharmaceuticals (NASDAQ: AMRX)
Amneal Pharmaceuticals is a specialty and generic pharmaceutical company developing and manufacturing products across various dosage forms and therapeutic areas. The company is accelerating its biosimilar efforts and positioning itself to close the valuation gap with industry peers, with strong Q1 2026 earnings driving increased confidence in its FY 2026 setup.
Zen Rating: Strong Buy (A) — see full analysis
Recent Price: Get current quote
Max 1-year forecast: $19.00
Why we're watching:
- Analyst support: All 3 analysts covering AMRX rate it Strong Buy, reflecting unanimous bullish sentiment on the company's biosimilar strategy and growth trajectory. See the ratings
- For example, UBS researcher Ashwani Verma (a top 11% rated analyst) recently initiated coverage with a Strong Buy rating and $19.00 price target, representing potential upside of +52.98%.
- It’s our Stock of the Week: Our Zen Investor Editor-in-Chief, Steve Reitmeister, is fully on board with the bullish case for AMRX. See his recent commentary here.
- Earnings momentum: The company delivered strong Q1 2026 results with analysts forecasting EPS growth of +158.92% year-over-year to reach $1.01, significantly outpacing the pharmaceutical industry average of 15.37% earnings growth.
- Industry ranking context: AMRX is currently the 5th highest-rated stock in the Pharmaceutical industry, which has an Industry Rating of B.
- Zen Rating highlights: AMRX is part of our top-rated tier of stocks, earning an A Zen Rating, which is equivalent to a Strong Buy recommendation.
- Component Grades: Each Zen Rating is composed of 7 Component Grades. The company demonstrates solid fundamentals across key metrics including Value (B), Sentiment (B), and Safety (B), positioning it well for continued upside. See all 7 Zen Component Grades here
2. Levi Strauss & Co (NYSE: LEVI)
Levi Strauss & Co. is an iconic global apparel company designing, marketing, and selling jeans, casual and dress pants, tops, and related accessories for men, women, and children. The company is transforming into a DTC-first denim lifestyle brand with strong Q1 2026 performance showing broad-based growth across channels, regions, and categories, supported by mid-single-digit revenue growth forecasts with mid-teens percentage margins over time.
Zen Rating: Strong Buy (A) — see full analysis
Recent Price: Get current quote
Max 1-year forecast: $34.00
Why we're watching:
- Analyst support: 5 analysts cover LEVI with 2 Strong Buy ratings and 3 Buy ratings, reflecting broad bullish sentiment with an average price target of $28.40 (+23.26% upside). See the ratings
- For example, UBS researcher Jay Sole (a top 7% rated analyst) recently raised their price target to $34.00 (+56.32% upside) following Q1 2026 earnings. Sole big-pictured that the company is "undertaking a transformation into a global, multi-channel, lifestyle brand for both men and women," predicting the transformation will support mid-single-digit revenue growth with mid-teens percentage margins over time.
- Exceptional Q1 2026 performance: The company delivered EPS of $0.42 vs. $0.37 estimate (13.5% beat) with revenue of $1.74B beating estimates by 5.45%, representing 13.68% year-over-year growth driven by the DTC-first strategy.
- Industry ranking context: LEVI is currently the #1 highest-rated stock in the Apparel Manufacturing industry, which has an Industry Rating of A.
- Zen Rating highlights: Strong Buy (A) stocks have historically averaged roughly 30% returns per year, putting LEVI in a class of historical outperformers.
- Component Grades: The company demonstrates well-rounded fundamentals with B grades across Value, Growth, Safety, and Financials, supporting the transformation strategy and long-term growth potential. See all 7 Zen Component Grades here
3. Brink's Co (NYSE: BCO)
The Brink's Company is a leading global security and protection company, best known for its bullet-resistant armored trucks providing security services to banks, retailers, governments, and mints worldwide. The company is projecting strong free cash flow growth with a 12% CAGR through FY 2030 and segment revenue growth at a 13% CAGR, driven by expanding incentive compensation systems linked to segment performance.
Zen Rating: Strong Buy (A) — see full analysis
Recent Price: Get current quote
Max 1-year forecast: $163.00
Why we're watching:
- Analyst support: Both analysts covering BCO rate it Strong Buy, with consensus price targets pointing to significant upside potential of 50% or more. See the ratings
- Truist Securities' Tobey Sommer (a top 14% rated analyst) recently maintained their Strong Buy rating with a $163.00 price target (+55.55% upside). Sommer noted that the company's free cash flow is expected to rise at a 12% CAGR through FY 2030, with segment revenue growing at a 13% CAGR, driven by expanding incentive compensation systems linked to segment growth.
- Financial strength: BCO demonstrates exceptional return on equity of 200.5%, significantly outpacing both the Security & Protection Service industry average of 50.45% and the broader market average of 147.3%.
- Earnings acceleration: Analysts forecast remarkable EPS growth of +116.53% year-over-year to $9.33, with current EPS at $4.31, reflecting strong operational momentum and market share gains.
- Industry ranking context: BCO is currently the #1 highest-rated stock in the Security & Protection Service industry, which has an Industry Rating of B.
- Zen Rating highlights: BCO ranks in the top 5% of stocks we track based on a 115-factor fundamental review, earning an overall Zen Rating of A, which amounts to a Strong Buy recommendation.
- Component Grades: The company excels with an A grade in Safety and B grades in Value, Growth, and Sentiment, demonstrating well-rounded investment appeal across multiple factors. See all 7 Zen Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.